Table 2.
Cancers Mentioned as First Response, among the First Three Responses and among the Ten Responses
| Cancer mentioned | Mentioned as first response | Mentioned in first 3 responses | Mentioned among all the responses |
|---|---|---|---|
| Breast | 219 (32.4%) | 367 (54.3%) | 560 (82.8%) |
| Lung | 77 (11.4%) | 274 (40.5%) | 540 (79.9%) |
| Colorectal | 111 (16.4%) | 285 (42.2%) | 483 (71.4%) |
| Head and neck* | 39 (5.8%) | 123 (18.2%) | 475 (70.2%) |
| Pancreas | 40 (5.9%) | 199 (29.4%) | 455 (67.3%) |
| Skin | 31 (4.6%) | 97 (14.3%) | 415 (61.4%) |
| Prostate | 24 (3.6%) | 115 (17.0%) | 357 (52.8%) |
| Leukaemia | 33 (4.9%) | 80 (11.8%) | 341 (50.4%) |
| Bone | 10 (1.5%) | 42 (6.2%) | 274 (40.5%) |
| Liver | 2 (0.3%) | 47 (7.0%) | 271 (40.1%) |
| Uterus | 3 (0.4%) | 60 (8.9%) | 246 (36.4%) |
| Oral cancer** | 29 (4.3%) | 65 (9.7%) | 233 (34.5%) |
| Lymphatic | 19 (2.8%) | 59 (8.7%) | 244 (36.1%) |
| Stomach | 6 (0.9 %) | 26 (3.8%) | 176 (26.0%) |
| Ovary | 2 (0.3%) | 39 (5.8%) | 164 (24.3%) |
*, Any mention of mouth, tongue, gingival, oral, head and neck, throat, or thyroid cancer; **, Any mention of mouth, tongue, gingival, or oral cancer.